Reconstituting Botulinum Toxin: Saline Volumes, Concentrations, and Technique

Reconstitution is the most frequently performed technical step in botulinum toxin practice, and one of the least frequently standardised. Most practitioners develop a reconstitution habit early in their career and repeat it indefinitely — often without a clear rationale for the saline volume they use, how it affects the dose per injection point, or how concentration influences clinical spread.

This matters more than most practitioners realise. An inconsistent reconstitution protocol is one of the most common causes of variable treatment outcomes in an otherwise technically competent injector. If the same 0.1ml of product delivers 10U in one session and 5U in the next because the reconstitution volume was doubled, the clinical result will differ — not because of patient variation, product quality, or injection technique, but because of a preparation step that took 30 seconds and was never standardised.

This guide covers everything practitioners need to know about botulinum toxin reconstitution: the correct saline to use, how to calculate the resulting concentration, how dilution affects clinical spread and duration, a step-by-step technique guide, and the specific reconstitution notes for Botulax (letibotulinumtoxinA, Hugel — South Korea), Nabota (prabotulinumtoxinA, Daewoong — South Korea), Bocouture (Xeomin), and Dysport — all available through or referenced alongside Celmade's product range.

For the full clinical background on botulinum toxin, see the Complete Guide to Botulinum Toxin Type A. For cold chain requirements that apply before reconstitution, see our Cold Chain and Storage guide.

Step 1: Choosing the Correct Diluent

The choice of diluent is not arbitrary. All major botulinum toxin manufacturers specify the diluent in their product Summary of Product Characteristics (SPC), and deviating from it can affect potency, product stability, and patient safety.

Use Preservative-Free 0.9% Normal Saline

Preservative-free 0.9% sodium chloride for injection is the correct and only recommended diluent for all major botulinum toxin Type A products, including Botulax, Nabota, Bocouture, and Dysport. The key word is preservative-free — bacteriostatic saline containing benzyl alcohol must not be used.

Step 2: Choosing Your Saline Volume — The Concentration Effect

The volume of saline you add to a botulinum toxin vial directly determines the concentration of product in the resulting solution — and this affects both the dose delivered per injection point and the practical spread of the product in tissue. Understanding this relationship is the foundation of consistent dosing.

The Core Formula

Concentration (U/ml) = Total units in vial ÷ Volume of saline added (ml)

From this, you can calculate the units delivered per 0.1ml (which is the typical injection volume per point):

Units per 0.1ml = Concentration (U/ml) ÷ 10

The table below shows the resulting concentration and units per 0.1ml for a standard 100U vial of Botulax or Nabota (both convert 1:1 with Botox-equivalent units) at the most commonly used saline volumes:

How Dilution Affects Spread and Clinical Results

One of the most clinically important — and least well understood — aspects of reconstitution is how the volume of diluent affects the practical behaviour of the product in tissue. This is not simply about dose: a higher volume of saline at the same unit dose physically places more fluid in the tissue and can influence how far the product diffuses from the injection site.

This relationship between dilution and spread is the scientific basis for a common clinical saying: 'dilution increases distribution'. However, it is important to understand that dilution does not increase the total units in the vial — it changes how many units are delivered per given volume and how broadly they spread. At the same total unit dose, a more dilute reconstitution spreads the same amount of product over a broader area, which can be clinically useful or clinically problematic depending on the zone being treated.

Step-by-Step Reconstitution Technique

The following protocol applies to Botulax, Nabota, and Bocouture — the three 1:1 Botox-equivalent products available in Celmade's range. Notes for Dysport follow separately. This sequence should become an ingrained, standardised routine:

1.     Gather equipment before starting. You need: the botulinum toxin vial (Botulax, Nabota, or Bocouture), preservative-free 0.9% normal saline for injection, a sterile drawing-up needle (21G or larger), a sterile injection syringe (1ml, 2ml, or 5ml depending on volume), an alcohol wipe, and a labelling pen or sticker.

2.     Remove the vial from the refrigerator and inspect it. Confirm the product name, batch number, and expiry date match what was ordered and recorded. Inspect the vial for cracks, particulates, or broken seals. The lyophilised contents should be a white to off-white dry cake or powder — no liquid should be present. For Bocouture: the vial may have been stored at room temperature — this is normal if the ambient temperature has been maintained below 25°C.

3.     Allow the vial to reach room temperature if recently refrigerated. Cold product can increase resistance during injection and may slightly alter the distribution of the reconstituted solution in tissue. 5–10 minutes at room temperature before reconstitution is sufficient.

4.     Wipe the vial stopper with an alcohol swab and allow to dry for 30 seconds. Do not proceed until the stopper is completely dry — residual alcohol can potentially interact with the protein at the needle insertion point.

5.     Draw up the chosen volume of preservative-free normal saline into the syringe. Use a 21G or larger drawing-up needle for efficiency. The typical volumes are 1ml, 2ml, or 2.5ml for a 100U vial depending on your preferred concentration. Confirm the volume is exactly correct by checking the syringe graduations at eye level.

6.     Insert the drawing-up needle into the vial stopper and allow saline to flow in by vacuum — do not force it. Most lyophilised botulinum toxin vials contain a partial vacuum, which draws the saline in gently when the needle is inserted. This is the preferred technique as it minimises mechanical stress on the protein. If the vial does not have a vacuum, inject the saline slowly and gently along the inside wall of the vial, not directly onto the powder. Directing saline forcefully onto the lyophilised cake can shear the protein and reduce potency.

7.     Gently swirl — do not shake. After saline enters the vial, gently rotate the vial in your hand to mix the powder into solution. The reconstituted product should be a clear, colourless solution with no visible particulates. Shaking introduces air bubbles and mechanical stress that can denature the protein. If the solution appears cloudy, discoloured, or contains visible particles, discard it and use a new vial.

8.     Label the vial immediately. Write or attach a label showing: product name, batch number, reconstitution time and date, saline volume used, resulting concentration (U/ml), and the use-by time. For Botulax and Bocouture this is 24 hours from reconstitution at 2–8°C; for Nabota this is 4 hours.

9.     Transfer to a 1ml syringe and change to the injection needle. Draw up the required amount into a 1ml Luer-lock syringe using the drawing-up needle, then attach the injection needle (30G, 31G, or 32G as appropriate for the treatment area). Change needles between each vial draw if treating multiple areas. Use a fresh syringe for each patient.

10.  Refrigerate any remaining reconstituted product immediately. Label the vial with the reconstitution time and store at 2–8°C. Use within the manufacturer-specified window. Do not freeze reconstituted product.

Product-Specific Reconstitution Notes

Botulax (100U and 200U) — Hugel, South Korea

Botulax reconstitutes cleanly and reliably with preservative-free normal saline. The lyophilised powder dissolves quickly once saline contacts it — in most vials, the powder is fully dissolved within 30–60 seconds of gentle swirling. Key notes:

•       Post-reconstitution shelf life: 4–24 hours at 2–8°C. Celmade recommends following the manufacturer's SPC guidance — check the current product insert for the validated window. Clinical practice typically uses within 8 hours for optimal potency assurance.

•       200U vial reconstitution: The 200U vial is particularly efficient for high-dose sessions. Reconstitute with 4ml saline to achieve 50 U/ml (5U per 0.1ml — identical protocol to a 100U vial reconstituted with 2ml). One 200U Botulax vial reconstituted with 4ml saline can cover a bilateral masseter treatment at 40U per side or a full bilateral axillary hyperhidrosis treatment at 50U per axilla with product to spare for a lip flip.

•       Concentration consistency: Because Botulax converts 1:1 with Botox-equivalent units, any reconstitution protocol you use for Botox applies directly to Botulax with no adjustment.

Nabota (100U and 200U) — Daewoong, South Korea

Nabota reconstitution is identical to Botulax in technique and saline requirements. The key difference is the post-reconstitution use window:

•       Post-reconstitution shelf life: 4 hours at 2–8°C per manufacturer guidance. This is the shortest window of the major products and has direct implications for session scheduling: reconstitute Nabota as close to the treatment time as possible. Do not reconstitute at the start of a long clinic day if the product will not be used for several hours.

•       Session planning for Nabota: For a clinic running back-to-back botulinum toxin appointments, Nabota works best when reconstituted immediately before the first patient. If two sessions are planned with a gap between them (e.g. morning and afternoon), reconstitute separately for each session rather than relying on product reconstituted in the morning remaining viable for afternoon use.

•       FDA approval context: Nabota (prabotulinumtoxinA) is the first Korean botulinum toxin Type A product to receive FDA approval, under the brand name Jeuveau in the USA. Its reconstitution protocol mirrors the FDA-approved version — practitioners can cross-reference the Jeuveau prescribing information as a secondary reference for reconstitution guidance.

Bocouture (Xeomin) — Merz, Germany

Bocouture is the protein-free ('naked') formulation and reconstitutes identically to protein-containing products from a technique perspective. Its specific advantages at the reconstitution stage are:

•       Room-temperature pre-reconstitution storage: Bocouture can be stored at up to 25°C before reconstitution, eliminating the need to remove it from a refrigerator and wait for it to reach room temperature. It is immediately ready for reconstitution when stored at ambient temperature.

•       Post-reconstitution shelf life: 24 hours at 2–8°C — the longest of the major products. This provides the most flexibility for session planning and allows a reconstituted vial to be used across multiple appointments within the same day.

•       1:1 dosing with Botulax and Nabota: All three products convert at 1:1 Botox-equivalent units. A practitioner who switches between Botulax and Bocouture uses an identical reconstitution protocol — same saline volume, same concentration, same units per 0.1ml.

Dysport (300U and 500U) — Ipsen

Dysport requires separate consideration because its unit system is different from the 1:1 Botox-equivalent products. The reconstitution volume chosen for Dysport affects not just concentration but also how the resulting dose relates to Botox-equivalent dosing:

The Most Common Reconstitution Errors and How to Avoid Them

Quick Reference: Reconstitution at a Glance

A summary of the key parameters for each product in the Celmade botulinum toxin range:

What to Document at Every Reconstitution

Every reconstitution event should be documented as part of your medicines management record. This protects you clinically, supports audit trails, and enables accurate outcome attribution across sessions. The minimum documentation for each reconstitution is:

•       Product name and vial size: e.g. Botulax 100U, or Nabota 200U

•       Batch number: from the vial label — required for traceability in the event of a product recall

•       Expiry date of the unopened vial: confirms the product was within shelf life

•       Date and time of reconstitution

•       Volume of saline used: e.g. 2.0ml — allows calculation of concentration

•       Resulting concentration: e.g. 50 U/ml — calculated from the formula

•       Use-by time: time of reconstitution plus the product-specific window

•       Name of person performing reconstitution

This information should be recorded in your clinic's medicines management log for the session, and the batch number should also be recorded in each patient's treatment record alongside the dose administered.

Key Takeaways

•       Preservative-free 0.9% normal saline is the only correct diluent — never use bacteriostatic saline (benzyl alcohol) or any other diluent.

•       Concentration = total units ÷ saline volume. Know your concentration before you draw up. At 2ml saline per 100U vial, each 0.1ml delivers 5U. At 1ml saline, each 0.1ml delivers 10U.

•       Botulax and Nabota reconstitute identically to Botox at 1:1 unit equivalence. Any protocol you use for Botox applies directly — same saline volume, same concentration, same dose per injection point. No conversion or adjustment needed.

•       Never shake — gently swirl. Shaking denatures the protein. Allow saline to enter by vacuum where possible and mix with a gentle rotation only.

•       Know your use-by window and label every vial: Botulax 24h · Nabota 4h · Bocouture 24h · Dysport 4–8h. Never use outside the window.

•       Standardise your reconstitution volume and never change it without recalculating. Variable reconstitution is one of the most common causes of inconsistent outcomes in otherwise competent practice.

•       Document every reconstitution: product, batch number, expiry, saline volume, concentration, and use-by time. This is both a regulatory requirement and your clinical audit trail.

Browse Celmade's full botulinum toxin range, including Botulax and Nabota in 50U, 100U, and 200U vials — all supplied with cold chain documentation and batch traceability. For related guides, see the Complete Guide to Botulinum Toxin Type A, our Cold Chain and Storage guide, the Unit Conversion reference, and our Upper Face Dosing guide.

Frequently Asked Questions

Does dilution affect how long botulinum toxin lasts?

Dilution itself — at standard clinical ranges — does not significantly affect duration of effect. Duration is primarily determined by total units delivered per muscle, the patient's individual metabolism, and the interval since the previous treatment. However, very high dilutions that result in significantly greater spread may 'dilute' the effect at the primary target muscle if units are dispersed over too wide an area, potentially giving the impression of shorter duration. The practical guidance is: use the dilution appropriate to your treatment area rather than varying it to attempt to influence duration.

Can I use the same reconstituted vial for multiple patients on the same day?

Only if strict infection control protocols are in place — single-use needles and syringes for each patient, no re-entry of a used needle into the shared vial, and the product is used within the manufacturer's post-reconstitution window. Many practitioners prefer to use individual vials per patient to eliminate any cross-contamination risk. For Nabota in particular, the 4-hour window constrains multi-patient use to a tightly scheduled session. Bocouture's 24-hour window is the most practical for multi-patient days.

Does it matter if I pull the saline in quickly vs slowly?

It matters at the point of saline entering the vial. Allowing saline to flow in by vacuum (by holding the vial inverted with the needle inserted) is the gentlest method. Injecting saline forcefully and directly onto the lyophilised powder creates a jet impact that can cause localised protein denaturation. The difference in practical outcome between vacuum-fill and careful side-wall injection is small, but forceful direct injection onto the powder is the one technique that has a demonstrable negative effect. Slow and gentle is always correct.

Is Botulax reconstitution the same as Botox reconstitution?

Yes — completely identical. Botulax (letibotulinumtoxinA, Hugel) is a 1:1 Botox-equivalent product. The same saline, the same volume, the same technique, the same resulting concentration, and the same post-reconstitution handling all apply. You do not need to learn a new protocol when switching from Botox to Botulax. Every reconstitution protocol you have developed for Botox translates directly.

What happens if I accidentally use too much saline?

The product is more dilute than intended — each 0.1ml delivers fewer units than expected. If you realise the error before treating, you can correct by drawing up a larger volume per injection point (to compensate for the lower concentration) or by increasing the number of injection points. If you do not realise it until results are assessed at the 2-week review, note the dilution in the patient record and increase to your standard volume at the next session. The product is not dangerous at higher dilution — it simply delivers fewer units per point, which typically results in an undertreated outcome that can be corrected at review.